Worldwide Synthetic Biology: DNA Cloning Industry to 2035 – Featuring Applied Biological Materials, ABP Biosciences and Addgene Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Synthetic Biology: DNA Cloning Market by Type of Cloning Method, End-Users and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering.

This report features an extensive study of the current market landscape and future potential of DNA cloning kits and reagents over the next decade. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies.

The field of gene cloning remained a largely unexplored area until 1973, when A. C. Y. Chang, H. W. Boyer, R. B. Helling and Stanley N. Cohen reported that individual genes can be cloned and isolated by cleaving DNA enzymatically into DNA fragments.

Over time, the evolution of genome engineering techniques has allowed for alterations in the genome of microorganisms, thereby enabling the production of substances having various research and therapeutic applications. DNA cloning, which is a highly regulated method, is widely acknowledged and employed in many laboratories throughout the world.

Specifically, during the COVID-19 pandemic, several well-known pharmaceutical and biopharmaceutical companies, as well as synthetic biology market players, have stepped forward and contributed to the research and development of a variety of products, such as test kits, treatment solutions, and vaccines to combat the coronavirus infection using synthetic biology.

Based on the requirement, a variety of approaches, such as traditional cloning, PCR cloning, ligation independent cloning, seamless cloning and recombinational cloning, can be used to clone the DNA. Despite several advancements in the field of synthetic biology, the DNA cloning process is associated with various challenges, such as requirement of large amounts of expensive vectors for cloning, different reagents and longer time duration for the completion of process.

In order to overcome these drawbacks, innovators in the pharmaceutical industry have undertaken several efforts for identifying and developing ways to improve the process of DNA cloning. Among other alternatives, the use of DNA cloning kits has emerged as a viable option for various drug developers and academic / research institutes to overcome the challenges associated with the traditional DNA cloning methods. Presently, more than 250 DNA cloning kits are available in the market.

These cloning kits are affordable, easy to use and produce high quality results in short duration. Further, more than 3,200 patents and 4,000 research articles have been published for DNA cloning technologies in the past few years; this is indicative of the innovative efforts of the stakeholders engaged in this domain. Driven by the increasing demand for gene therapies and the introduction of novel and advanced DNA cloning technologies, the DNA cloning market is anticipated to witness steady growth in the coming years.

Companies Mentioned

• AbFrontier
• Applied Biological Materials
• ABP Biosciences
• Addgene
• Agilent Technologies
• America Diagnostics
• Amid Biosciences
• AMSBIO
• Applied Biosystems
• AstraZeneca
• Biocompare
• Bio-Fab Research
• Bioline (acquired by Meridian Bioscience)
• Biomiga
• Bioneer
• Bionics
• Bio-Rad Laboratories
• BioServ
• BIOSS Centre for Biological Signalling Studies
• Blue Heron Biotech (acquired by Eurofins Genomics)
• Broad Institute
• Boston University Medical Campus (BUMC)
• Cambridge Bioscience
• Canvax Biotech
• Cellecta
• Cellomics Technology
• Charles River Laboratories
• Chromous Biotech
• Codex DNA
• Columbia University
• Columbia University Irving Medical Center (CUIMC)
• Commonwealth Scientific and Industrial Research Organisation (CSIRO)
• Creative Biogene
• And Many More Companies!

Key Questions Answered

• Who are the key players engaged in the development of DNA cloning kits and reagents?
• What is the focus area of various publications related to DNA cloning?
• Which research institutes have received relatively more grants for projects related to DNA cloning?
• How has the intellectual property landscape of DNA cloning evolved over the last several years?
• Which region(s) are likely to occupy the maximum market share in DNA cloning kits market?
• Which factors are likely to influence the evolution of this market?
• How is the current and future market opportunity related to DNA cloning kits likely to be distributed across key market segments?
• Who are the key players offering services related to DNA cloning?

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE: DNA CLONING KITS

5. MARKET LANDSCAPE: DNA CLONING REAGENTS

6. DNA CLONING KITS AND REAGENTS: COMPANY PROFILES

7. PUBLICATION ANALYSIS

8. GRANT ANALYSIS

9. PATENT ANALYSIS

10. MARKET FORECAST AND OPPORTUNITY ANALYSIS

11. CASE STUDY: DNA CLONING SERVICE PROVIDERS

12. EVOLUTION OF DNA CLONING

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information about this report visit https://www.researchandmarkets.com/r/h7oyzr

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900